The secret to Germany's FP6 success

Germany took the opportunity to look back at its impressive performance in the Sixth Framework Programme (FP6) as it held a national launch event for FP7 in Bonn on 15 and 16 January.

Germany is ranked first among all participating countries for FP6. The latest available statistics from the European Commission show 7,449 German participations in 3,027 FP6 contracts, with a total EU contribution to German participants of around €2.3 billion. Overall, German researchers participated in 82% of FP6 projects and received nearly 19% of the overall FP6 budget. Proposals involving Germany also had a 24% success rate - significantly higher than the EU average of 18%.

These figures come as no surprise when one considers how much the country invests in its national research base. According to preliminary figures from Eurostat for 2005, Germany is one of the highest investors in research in Europe, spending 2.51% of its GDP on research and development (R&D). In 2007, the German Government says it will increase its funding for research to €10 billion.

However, the secret of Germany's success in FP6 does not lie in investment alone, but in the nature of the national research base, according to Klaus Uckel of the German Federal Ministry for Education and Research (BMBF). "For us the focus has been on creating excellence," he told CORDIS News, and by providing researchers with access to continued institutional and project support, whether it be at Länder (regional), federal or EU level.

Germany's approach to funding differs somewhat from that of other Member States. Mr Uckel pointed to the UK as an example, where researchers cannot apply for national funding if resources are available at EU level. "We didn't want to stress our scientists out by saying: "you will only get money at national level which you cannot get at EU level", explained Mr Uckel. He highlighted the potential dangers of cordoning off national funding in such a way. "This could lead to an even higher oversubscription of the framework programme budget and result in weakening scientific excellence overall: because what will these scientists do if their EU proposal is not successful or if the EU money runs out?" he asked.

The German 'open' funding mechanism is much more advantageous, believes Mr Uckel, since it helps to train researchers, giving them the experience they need in their field as well as acquainting them with the fine art of grant application. 'We always say that it is good training for young researchers to practice applying for grants first at national level and then based on the experience they obtained, to see whether they can go forward and apply for an EU grant,' he explained.

Also key to Germany's successful participation in FP6 is ensuring that the national research agenda reflects what is happening at EU level, and vice versa. "We are really trying to find coherence between the national and EU programmes. When we are planning the national thematic areas, we are paying close attention to the EU framework programme," said Mr Uckel. "That way those interested in participating in projects know at an early stage about our plans and what is on the agenda, both at national and EU level." Aligning national and EU thematic areas would appear to have paid off. According to Mr Uckel, Germany achieved success rates above the EU average in nearly all thematic areas of FP6, with the exception of food quality and safety.

Germany has also managed to bring onboard industry more successfully than many of the other participating countries. According to the latest statistics, there were as many participants in FP6 coming from German industry as there were from academia and public research institutes.

"The fact that industry is participating on an equal footing shows that the exchange or transfer of knowledge is very healthy in Germany," said Mr Uckel. During the planning of FP7, German industry stakeholders called for a greater focus on the needs and interests of industry.

"But this data is showing the framework programme has already been of interest to German industry. Industry themselves didn't realise they were participating to this extent. They are very happy with these indicators," said Mr Uckel. He believes the figures will further encourage industry partners to participate.

Helping the Education and Research Ministry to raise awareness of EU funding opportunities is the network of German national contact points (NCP), which has grown to cover both the thematic areas and horizontal areas of the framework programme. Mr Uckel believes that the network has been hugely instrumental in helping applicants to find their way through the complex application procedure, providing a lot of support on anything from legal and intellectual property rights (IPR) questions to responding to calls.

The NCP network has also significantly contributed to discussions on the structuring and content of FP7. "The ministry has taken a bottom-up approach to gain feedback on the thematic priorities and participants' experience of the framework programme. Thanks to this feedback, Germany was able to come up with suggestions to simplify the application procedures in FP7," explained Mr Uckel.

Looking towards FP7, Mr Uckel said that Germany, as one of the largest Member States, would be looking to help smaller countries in the Union to get involved in the framework programme. "As a big industrial country, Germany has social responsibility towards the new Member States," he said. Already in FP6, the ministry set up a Contact Point for the new Member States and accession countries and those researchers and institutes in Germany that are interested in working with partners from the Accession States.

As for Germany's own involvement, Mr Uckel says he is confident that his country will maintain its high performance, winning more project contracts. Judging by the number of researchers packing into the workshops at the FP7 launch event, Germany looks set for another successful framework programme.

For more information about Germany's R&D performance, please visit:
http://www.bmbf.de/en/index.php

Copyright ©European Communities, 2007
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Clanwilliam Brings Epic Care to the UK

Care homes looking to digitise their administration and care procedures have a new option with the launch of Epic Care in the UK. Epic Care is a modular, scalable system developed...

AI Language Models Write Good Doctor…

Generative AI should be able to write usable doctor's letters and thus potentially speed up medical documentation, according to a study by the University Medical Center Freiburg. Around 93% of...

West Yorkshire and Harrogate Hospitals S…

Clinicians working at five of the six trusts in the West Yorkshire Association of Acute Trusts (WYAAT) can access test results from across their pathology network, following a summer roll-out...

ChatGPT Shows Human-Level Assessment of …

As artificial intelligence advances, its uses and capabilities in real-world applications continue to reach new heights that may even surpass human expertise. In the field of radiology, where a correct...

When Detecting Depression, the Eyes have…

It has been estimated that nearly 300 million people, or about 4% of the global population, are afflicted by some form of depression. But detecting it can be difficult, particularly...

When it comes to Emergency Care, ChatGPT…

If ChatGPT were cut loose in the Emergency Department, it might suggest unneeded x-rays and antibiotics for some patients and admit others who didn't require hospital treatment, a new study...

HWL 2024 Brings Together a Record Number…

1 - 2 October 2024, Luxembourg. The second edition of Healthcare Week Luxembourg on 1 and 2 October 2024, organised by the Federation of Luxembourg Hospitals (FHL), in partnership with the...

AI Drives Development of Cancer Fighting…

University of Houston researchers and their students are developing a new software technology, based on artificial intelligence, for advancing cell-based immunotherapy to treat cancer and other diseases. CellChorus...

MEDICA 2024 + COMPAMED 2024: Adapted Hal…

11 - 14 November 2024, Düsseldorf, Germany. The final preparations for MEDICA 2024 and COMPAMED 2024 in Düsseldorf have begun. A total of more than 5,500 exhibitors from approximately 70 countries...

Revolutionizing Cardiovascular Risk Asse…

A recent position paper in the Asia-Pacific Journal of Ophthalmology explores the transformative potential of artificial intelligence (AI) in ophthalmology. Led by Lama Al-Aswad, Professor of Ophthalmology and Irene Heinz...

AI does Not Necessarily Lead to more Eff…

The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long...

Why the NHS Needs a Transparency Revolut…

Opinion Article by Dr Mark Ratnarajah, NHS paediatrician and UK Managing Director for C2-Ai. Wes Streeting wanted 'no stone left unturned' when he asked Lord Darzi to examine the current state...